AtomNet
Drug design with convolutional neural networks
Using artificial intelligence for structure-based drug discovery (SBDD).
Atomwise uses Deep Learning Neural Networks to help discover new medicines. Atomwise achieves the world’s best results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, startups, and research institutions.